HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Francisco Vega Selected Research
Francisco Vega Research Topics
Disease
48
Neoplasms (Cancer)
02/2024 - 04/2000
29
Lymphoma (Lymphomas)
03/2024 - 04/2006
17
B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 01/2011
13
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 10/2009
10
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2022 - 05/2002
9
Hodgkin Disease (Hodgkin's Disease)
12/2023 - 11/2011
8
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2024 - 06/2011
6
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 04/2002
6
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 08/2011
5
Hypersensitivity (Allergy)
11/2022 - 01/2012
4
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 06/2007
4
T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 09/2003
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 10/2009
4
Genetic Translocation (Chromosomal Translocation)
09/2020 - 04/2002
3
Inflammation (Inflammations)
01/2023 - 01/2019
3
Urticaria (Hives)
04/2019 - 10/2010
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 03/2016
3
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018 - 05/2002
2
Hyperplasia
03/2024 - 01/2021
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2019
2
Breast Neoplasms (Breast Cancer)
01/2022 - 09/2008
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019 - 02/2002
2
Glioma (Gliomas)
05/2013 - 11/2011
2
Multiple Myeloma
08/2011 - 06/2005
1
Sialadenitis
10/2023
1
Cytopenia
01/2023
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2022
1
Thrombocytopenia (Thrombopenia)
06/2022
1
Cytokine Release Syndrome
01/2022
Drug/Important Bio-Agent (IBA)
15
Proteins (Proteins, Gene)
FDA Link
06/2022 - 04/2000
9
Rituximab (Mabthera)
FDA Link
11/2023 - 12/2013
7
RNA (Ribonucleic Acid)
IBA
01/2023 - 06/2005
7
Biomarkers (Surrogate Marker)
IBA
01/2022 - 09/2008
5
Chimeric Antigen Receptors
IBA
02/2024 - 01/2022
5
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2023 - 12/2013
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2023 - 12/2013
4
Cytokines
IBA
11/2023 - 01/2019
4
Antigens
IBA
11/2023 - 02/2002
4
Anaplastic Lymphoma Kinase
IBA
06/2022 - 07/2006
4
Adenosine Triphosphate (ATP)
IBA
01/2018 - 10/2009
3
Chromatin
IBA
03/2024 - 11/2018
3
Brentuximab Vedotin
IBA
12/2023 - 01/2018
3
Vincristine (Oncovin)
FDA Link
Generic
11/2023 - 12/2013
3
ibrutinib
IBA
01/2023 - 01/2022
3
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2023 - 02/2002
3
Antibodies
IBA
02/2012 - 04/2006
2
Prednisone (Sone)
FDA Link
Generic
11/2023 - 12/2013
2
Lenalidomide (CC 5013)
FDA Link
01/2023 - 01/2022
2
Immunoglobulin E (IgE)
IBA
11/2022 - 10/2010
2
Immunoglobulin G (IgG)
IBA
11/2022 - 04/2020
2
Phosphotransferases (Kinase)
IBA
06/2022 - 01/2011
2
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2022 - 12/2013
2
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 12/2013
2
Cyclin D1
IBA
01/2022 - 01/2018
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 12/2013
2
Uracil-DNA Glycosidase
IBA
03/2021 - 09/2020
2
venetoclax
IBA
01/2021 - 01/2020
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 01/2019
2
Alemtuzumab (Campath)
FDA Link
01/2019 - 05/2002
2
Oncogene Proteins (Oncogene Protein)
IBA
11/2018 - 01/2013
2
Transcription Factors (Transcription Factor)
IBA
11/2018 - 11/2011
2
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
11/2018 - 01/2011
2
Enzymes
IBA
11/2018 - 10/2002
2
TNF Receptor-Associated Factor 6 (TRAF6)
IBA
11/2018 - 06/2013
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
09/2015 - 06/2011
2
MicroRNAs (MicroRNA)
IBA
08/2013 - 01/2013
2
Messenger RNA (mRNA)
IBA
02/2012 - 06/2011
2
Pyridinolcarbamate (P23)
IBA
07/2006 - 05/2002
2
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
11/2002 - 04/2002
1
Enhancer of Zeste Homolog 2 Protein
IBA
03/2024
1
Biological Factors
IBA
01/2024
1
Vinblastine (Vinblastine Sulfate)
FDA Link
12/2023
1
Dacarbazine (DIC)
FDA Link
Generic
12/2023
1
Circulating Tumor DNA
IBA
11/2023
1
Iohexol (Omnipaque)
FDA Link
10/2023
1
iobitridol
IBA
10/2023
1
iopromide (Ultravist)
FDA Link
10/2023
1
Antioxidants
IBA
01/2023
1
Interferons
IBA
01/2023
1
Thrombopoietin (c-mpl Ligand)
IBA
01/2023
1
Neutralizing Antibodies
IBA
01/2023
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2022
1
Alarmins
IBA
11/2022
1
Complement System Proteins (Complement)
IBA
11/2022
1
Interleukin-13
IBA
11/2022
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
06/2022
1
Transaminases (Aminotransferases)
IBA
06/2022
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022
1
Insulin-Like Peptides
IBA
01/2022
1
omega-Chloroacetophenone (Mace)
IBA
01/2022
1
tocilizumab (atlizumab)
FDA Link
01/2022
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2022
1
CD19-specific chimeric antigen receptor
IBA
01/2022
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
01/2022
1
Capsules (Microcapsules)
IBA
12/2021
Therapy/Procedure
19
Therapeutics
12/2023 - 05/2002
14
Drug Therapy (Chemotherapy)
01/2023 - 02/2002
4
Breast Implants (Breast Implant)
11/2023 - 01/2018
1
Stem Cell Transplantation
01/2023
1
Preoperative Exercise
10/2022